Strategic Global Advisors, LLC United Therapeutics Corp Transaction History

Strategic Global Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$76.06 - $120.81 $749,723 - $1.19 Million	-9,857 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$107.15 - $126.84 $192,334 - $227,677	1,795 Added 22.26%	9,857 $1.16 Million
Q4 2018 Feb 13, 2019	SELL	$101.4 - $128.73 $72,703 - $92,299	-717 Reduced 8.17%	8,062 $878,000
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $137,823 - $156,776	-1,211 Reduced 12.12%	8,779 $1.12 Million
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $45,060 - $57,486	-380 Reduced 3.66%	9,990 $1.48 Million

Q3 2017 Nov 13, 2017	BUY	$114.6 - $136.81 $1.19 Million - $1.42 Million	10,370	10,370 $1.22 Million

561

43.1M

501K

529K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Strategic Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Global Advisors, LLC with notifications on news.